Savara company logo
Savara
Actively Hiring
Inhaled antibiotic for MRSA in CF 51-200 Employees

Savara careers

Inhaled antibiotic for MRSA in CF
Savara is an inhalation drug development company.

Our lead product addresses an unmet clinical need in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis (CF) and in other high risk patient populations. MRSA is a growing problem, with a 6 year reduction in life expectancy for infected CF patients and no suitable treatment. The product is in preparation for its first human clinical trial.

Senior Director, Data Privacy (Attorney- Remote US)

Remote only • United States
$250k – $290k
2 weeks ago

Executive Director, Information Technology (hybrid)

In office • Langhorne
$230k – $275k
2 weeks ago

Senior Director, Quality Assurance (Drug Product)- Remote US

Remote only • United States
$220k – $245k
1 month ago
Chris Condit
Avatar for Chris Condit
R&D engineer w/ CardioSpectra (sold to Volcano), founded SpectraPhase. Earned BS in electrical engineering and MS in Biomedical Engineering from UT Austin.
Chris Marich
Avatar for Chris Marich
Rob Neville
Avatar for Rob Neville
Founder @Evity (sold to BMC software) $100M funded with one angel round
Valuation

$152M

Funded over

1 round

Latest round

IPO (Apr 2017)